199 related articles for article (PubMed ID: 20304625)
1. Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree?
Bayley JP; Devilee P
Curr Opin Genet Dev; 2010 Jun; 20(3):324-9. PubMed ID: 20304625
[TBL] [Abstract][Full Text] [Related]
2. Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency.
Favier J; Brière JJ; Strompf L; Amar L; Filali M; Jeunemaitre X; Rustin P; Gimenez-Roqueplo AP;
Horm Res; 2005; 63(4):171-9. PubMed ID: 15795514
[TBL] [Abstract][Full Text] [Related]
3. Decoding Warburg's hypothesis: tumor-related mutations in the mitochondrial respiratory chain.
Garcia-Heredia JM; Carnero A
Oncotarget; 2015 Dec; 6(39):41582-99. PubMed ID: 26462158
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial tumour suppressors: a genetic and biochemical update.
Gottlieb E; Tomlinson IP
Nat Rev Cancer; 2005 Nov; 5(11):857-66. PubMed ID: 16327764
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP
Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702
[TBL] [Abstract][Full Text] [Related]
6. 'The metabolism of tumours': 70 years later.
Semenza GL; Artemov D; Bedi A; Bhujwalla Z; Chiles K; Feldser D; Laughner E; Ravi R; Simons J; Taghavi P; Zhong H
Novartis Found Symp; 2001; 240():251-60; discussion 260-4. PubMed ID: 11727934
[TBL] [Abstract][Full Text] [Related]
7. Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.
Vicha A; Taieb D; Pacak K
Endocr Relat Cancer; 2014 Jun; 21(3):R261-77. PubMed ID: 24500761
[TBL] [Abstract][Full Text] [Related]
8. [From gene to disease; from SDHD, a defect in the respiratory chain, to paragangliomas and pheochromocytomas].
Taschner PE; Bröcker-Vriends AH; van der Mey AG
Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2188-90. PubMed ID: 12467161
[TBL] [Abstract][Full Text] [Related]
9. A role for mitochondrial enzymes in inherited neoplasia and beyond.
Eng C; Kiuru M; Fernandez MJ; Aaltonen LA
Nat Rev Cancer; 2003 Mar; 3(3):193-202. PubMed ID: 12612654
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria in cancer: not just innocent bystanders.
Frezza C; Gottlieb E
Semin Cancer Biol; 2009 Feb; 19(1):4-11. PubMed ID: 19101633
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Deficiencies in the Predisposition to Paraganglioma.
Lussey-Lepoutre C; Buffet A; Gimenez-Roqueplo AP; Favier J
Metabolites; 2017 May; 7(2):. PubMed ID: 28471419
[TBL] [Abstract][Full Text] [Related]
12. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.
King A; Selak MA; Gottlieb E
Oncogene; 2006 Aug; 25(34):4675-82. PubMed ID: 16892081
[TBL] [Abstract][Full Text] [Related]
13. Pheochromocytomas: from genetic diversity to new paradigms.
Qin Y; Buddavarapu K; Dahia PL
Horm Metab Res; 2009 Sep; 41(9):664-71. PubMed ID: 19391076
[TBL] [Abstract][Full Text] [Related]
14. Inborn and acquired metabolic defects in cancer.
Frezza C; Pollard PJ; Gottlieb E
J Mol Med (Berl); 2011 Mar; 89(3):213-20. PubMed ID: 21301796
[TBL] [Abstract][Full Text] [Related]
15. The Warburg effect and mitochondrial stability in cancer cells.
Gogvadze V; Zhivotovsky B; Orrenius S
Mol Aspects Med; 2010 Feb; 31(1):60-74. PubMed ID: 19995572
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
Desideri E; Vegliante R; Ciriolo MR
Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
[TBL] [Abstract][Full Text] [Related]
17. New advances in the genetics of pheochromocytoma and paraganglioma syndromes.
Gimenez-Roqueplo AP
Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078
[TBL] [Abstract][Full Text] [Related]
18. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
Laurenti G; Tennant DA
Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
[TBL] [Abstract][Full Text] [Related]
19. Cells silenced for SDHB expression display characteristic features of the tumor phenotype.
Cervera AM; Apostolova N; Crespo FL; Mata M; McCreath KJ
Cancer Res; 2008 Jun; 68(11):4058-67. PubMed ID: 18519664
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
